ADENOSINE
NDC 51662-1631, ADENOSINE, injection, from HF Acquisition Co LLC, DBA HealthFirst.
- Product NDC
- 51662-1631
- Status
- Listed
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078686
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1631 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ADENOSINE3 mg/mL
Pharmacologic classes
Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51662-1631-1 | 51662163101 | 2 mL in 1 VIAL, SINGLE-DOSE (51662-1631-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fa6eb0f8-7c41-2e17-e053-6294a90ac8ca
Use it
Look up 51662-1631 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1631 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51662-1631. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.